Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025Elke Roeb, Martina Sterneck, Andrea Tannapfel et al.|Zeitschrift für Gastroenterologie|2022Cited by 92
MicroRNA-26b protects against MASH development in mice and can be efficiently targeted with lipid nanoparticlesLinsey J. F. Peters, Emiel P. C. van der Vorst, Leonida Rakateli et al.|eLife|2025Cited by 2
MicroRNA-26b protects against MASH development and can be efficiently targeted with lipid nanoparticlesLinsey J. F. Peters, Emiel P. C. van der Vorst, Leonida Rakateli et al.|Unknown|2024Cited by 0
MicroRNA-26b protects against MASH development in mice and can be efficiently targeted with lipid nanoparticlesLinsey J. F. Peters, Emiel P. C. van der Vorst, Leonida Rakateli et al.|eLife|2024Cited by 0
Author response: MicroRNA-26b protects against MASH development and can be efficiently targeted with lipid nanoparticlesLinsey J. F. Peters, Emiel P. C. van der Vorst, Leonida Rakateli et al.|Unknown|2024Cited by 0